Objective: To investigate the contribution of the total antioxidant capacity (TAC) of the diet to plasma concentrations of b-carotene. Design: Cross-sectional study. Setting: Department of Public Health and Department of Internal Medicine and Biomedical Sciences, University of Parma. Subjects: A total of 247 apparently healthy adult men (n ¼ 140) and women (n ¼ 107). Methods: A medical history, a physical exam including height, weight, waist circumference and blood pressure measurements, a fasting blood draw, an oral glucose tolerance test and a 3-day food record. Results: We observe a negative trend across quartiles of plasma b-carotene for most biological variables clustering in the insulin resistance syndrome, as well as for traditional and new risk factors for type II diabetes and cardiovascular disease (CVD), including C-reactive protein and g-glutamyltranspeptidase (Po0.05). Regarding dietary characteristics, energy-adjusted intake of fat, fiber, fruits, vegetables, b-carotene, vitamin C, vitamin E and dietary TAC significantly increased with increasing plasma b-carotene (Po0.05), whereas alcohol intake decreased (P ¼ 0.013). Adjusted geometric means (95% confidence interval) of plasma b-carotene significantly increased across quartiles of dietary TAC, even when single dietary antioxidants were considered in the model (QI ¼ 0.087 mg/dl (0.073-0.102); QII ¼ 0.087 mg/dl (0.075-0.103); QIII ¼ 0.114 mg/dl (0.098-0.132) and QIV ¼ 0.110 mg/dl (0.093-0.130); P for linear trend ¼ 0.026). When the population was divided on the basis of alcohol consumption, this trend was also observed in subjects drinking o20 g alcohol/day (P ¼ 0.034), but not in those with higher alcohol intake (P ¼ 0.448). Conclusions: Dietary TAC is an independent predictor of plasma b-carotene, especially in moderate alcohol drinkers. This may explain, at least in part, the inverse relationship observed between plasma b-carotene and risk of chronic diseases associated to high levels of oxidative stress (i.e., diabetes and CVD), as well as the failure of b-carotene supplements alone in reducing such risk. Contributors: SV participated in the study design and the collection of clinical data, performed the statistical analysis and was the primary writer of the paper, but received input from all the other authors. DDR contributed to the preparation of the paper, to laboratory analysis and to the study design. NP provided expert advice and was involved in paper editing and data interpretation. DA and LF participated in subjects' recruitment and management, in the collection and interpretation of clinical data and in the discussion of the paper. PMP and SS were involved in laboratory analysis and quality control. PR carried out the analysis of plasma b-carotene and provided expert advice on data interpretation. DDR, NP, SS and FB were responsible for the collection, completeness and interpretation of dietary data. IZ was responsible for ethical approval and subjects' recruitment. IZ and FB were responsible for the study concept and design and for sec...